Sionna Therapeutics (SION) Cash from Investing Activities (2024 - 2026)

Sionna Therapeutics (SION) has 3 years of Cash from Investing Activities data on file, last reported at $24.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 117.58% year-over-year to $24.8 million; the trailing twelve-month figure through Mar 2026 stood at $47.3 million (up 132.78% YoY), and the FY2025 full-year result was -$118.7 million, up 6.43% from the prior year.
• Cash from Investing Activities climbed to $24.8 million in Q1 2026, from $22.6 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $24.8 million in Q1 2026 to a low of -$141.2 million in Q1 2025.
• A 3-year average of -$24.5 million and a median of $10.4 million in 2024 frame the typical range for Cash from Investing Activities.
• Peak annual rise in Cash from Investing Activities reached 121.99% in 2025, while the deepest fall reached 13.93% in 2025.
• Tracing SION's Cash from Investing Activities over 3 years: stood at $15.2 million in 2024, then jumped by 48.33% to $22.6 million in 2025, then grew by 9.88% to $24.8 million in 2026.
• Business Quant data shows SION's Cash from Investing Activities at $24.8 million in Q1 2026, $22.6 million in Q4 2025, and $23.1 million in Q3 2025.